Eye treatments have evolved dramatically in the past decade, says Mark Blumenkranz, MD, an ophthalmologist. Macular degeneration, for example, has gone from a blinding disease to a highly treatable condition. Learn more in this video.
Read Transcript
Well, we've made enormous, enormous strides in Macular Degeneration in the last 8-10 years, just breathtaking. As I said, I think we've really moved from those being irreversible, universally blinding diseases to being very treatable.
Mark S. Blumenkranz, MD, is the H.J. Smead Professor and Chairman of the Department of Ophthalmology at Stanford University. Dr. Blumenkranz’s primary clinical interests center on medical and surgical treatment of vitreoretinal diseases.
